These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26551248)

  • 1. Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial Respiration.
    van der Westhuyzen R; Winks S; Wilson CR; Boyle GA; Gessner RK; Soares de Melo C; Taylor D; de Kock C; Njoroge M; Brunschwig C; Lawrence N; Rao SP; Sirgel F; van Helden P; Seldon R; Moosa A; Warner DF; Arista L; Manjunatha UH; Smith PW; Street LJ; Chibale K
    J Med Chem; 2015 Dec; 58(23):9371-81. PubMed ID: 26551248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
    Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 4-Amino-Thieno[2,3-
    Harrison GA; Mayer Bridwell AE; Singh M; Jayaraman K; Weiss LA; Kinsella RL; Aneke JS; Flentie K; Schene ME; Gaggioli M; Solomon SD; Wildman SA; Meyers MJ; Stallings CL
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31511370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents.
    Ng PS; Manjunatha UH; Rao SP; Camacho LR; Ma NL; Herve M; Noble CG; Goh A; Peukert S; Diagana TT; Smith PW; Kondreddi RR
    Eur J Med Chem; 2015 Dec; 106():144-56. PubMed ID: 26544629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrazolo[1,5- a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis.
    Lu X; Williams Z; Hards K; Tang J; Cheung CY; Aung HL; Wang B; Liu Z; Hu X; Lenaerts A; Woolhiser L; Hastings C; Zhang X; Wang Z; Rhee K; Ding K; Zhang T; Cook GM
    ACS Infect Dis; 2019 Feb; 5(2):239-249. PubMed ID: 30485737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis.
    Lupien A; Foo CS; Savina S; Vocat A; Piton J; Monakhova N; Benjak A; Lamprecht DA; Steyn AJC; Pethe K; Makarov VA; Cole ST
    PLoS Pathog; 2020 Jan; 16(1):e1008270. PubMed ID: 31971990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB.
    Cleghorn LAT; Ray PC; Odingo J; Kumar A; Wescott H; Korkegian A; Masquelin T; Lopez Moure A; Wilson C; Davis S; Huggett M; Turner P; Smith A; Epemolu O; Zuccotto F; Riley J; Scullion P; Shishikura Y; Ferguson L; Rullas J; Guijarro L; Read KD; Green SR; Hipskind P; Parish T; Wyatt PG
    J Med Chem; 2018 Aug; 61(15):6592-6608. PubMed ID: 29944372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.
    Singh S; Roy KK; Khan SR; Kashyap VK; Sharma A; Jaiswal S; Sharma SK; Krishnan MY; Chaturvedi V; Lal J; Sinha S; Dasgupta A; Srivastava R; Saxena AK
    Bioorg Med Chem; 2015 Feb; 23(4):742-52. PubMed ID: 25614114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization.
    Soares de Melo C; Feng TS; van der Westhuyzen R; Gessner RK; Street LJ; Morgans GL; Warner DF; Moosa A; Naran K; Lawrence N; Boshoff HI; Barry CE; Harris CJ; Gordon R; Chibale K
    Bioorg Med Chem; 2015 Nov; 23(22):7240-50. PubMed ID: 26522089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing.
    Subtil FT; Villela AD; Abbadi BL; Rodrigues-Junior VS; Bizarro CV; Timmers LFSM; de Souza ON; Pissinate K; Machado P; López-Gavín A; Tudó G; González-Martín J; Basso LA; Santos DS
    Int J Antimicrob Agents; 2018 Mar; 51(3):378-384. PubMed ID: 28843821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation.
    Biava M; Porretta GC; Poce G; De Logu A; Meleddu R; De Rossi E; Manetti F; Botta M
    Eur J Med Chem; 2009 Nov; 44(11):4734-8. PubMed ID: 19595488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.
    Moraski GC; Seeger N; Miller PA; Oliver AG; Boshoff HI; Cho S; Mulugeta S; Anderson JR; Franzblau SG; Miller MJ
    ACS Infect Dis; 2016 Jun; 2(6):393-8. PubMed ID: 27627627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis.
    Liu P; Yang Y; Ju Y; Tang Y; Sang Z; Chen L; Yang T; An Q; Zhang T; Luo Y
    Bioorg Chem; 2018 Oct; 80():422-432. PubMed ID: 30005200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel class of quinoline-oxadiazole hybrids as anti-tuberculosis agents.
    Jain PP; Degani MS; Raju A; Anantram A; Seervi M; Sathaye S; Ray M; Rajan MGR
    Bioorg Med Chem Lett; 2016 Jan; 26(2):645-649. PubMed ID: 26675440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.
    Panda M; Ramachandran S; Ramachandran V; Shirude PS; Humnabadkar V; Nagalapur K; Sharma S; Kaur P; Guptha S; Narayan A; Mahadevaswamy J; Ambady A; Hegde N; Rudrapatna SS; Hosagrahara VP; Sambandamurthy VK; Raichurkar A
    J Med Chem; 2014 Jun; 57(11):4761-71. PubMed ID: 24818517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursolic acid as a potential inhibitor of Mycobacterium tuberculosis cytochrome bc1 oxidase-a molecular modelling perspective.
    Tembe N; Machaba KE; Ndagi U; Kumalo HM; Mhlongo NN
    J Mol Model; 2022 Jan; 28(2):35. PubMed ID: 35022913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB.
    Abrahams KA; Cox JA; Spivey VL; Loman NJ; Pallen MJ; Constantinidou C; Fernández R; Alemparte C; Remuiñán MJ; Barros D; Ballell L; Besra GS
    PLoS One; 2012; 7(12):e52951. PubMed ID: 23300833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrB.
    Chandrasekera NS; Berube BJ; Shetye G; Chettiar S; O'Malley T; Manning A; Flint L; Awasthi D; Ioerger TR; Sacchettini J; Masquelin T; Hipskind PA; Odingo J; Parish T
    ACS Infect Dis; 2017 Dec; 3(12):898-916. PubMed ID: 29035551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis.
    Urban M; Šlachtová V; Brulíková L
    Eur J Med Chem; 2021 Feb; 212():113139. PubMed ID: 33422979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.
    Gold B; Smith R; Nguyen Q; Roberts J; Ling Y; Lopez Quezada L; Somersan S; Warrier T; Little D; Pingle M; Zhang D; Ballinger E; Zimmerman M; Dartois V; Hanson P; Mitscher LA; Porubsky P; Rogers S; Schoenen FJ; Nathan C; Aubé J
    J Med Chem; 2016 Jul; 59(13):6027-44. PubMed ID: 27144688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.